Word

TRIGENESIS

Status

Dead

Status Code

606

Status Date

Monday, January 16, 2023

Serial Number

88811637

Mark Type

4000

Filing Date

Wednesday, February 26, 2020

Published for Opposition

Tuesday, April 21, 2020

Abandoned Date

Monday, January 16, 2023

Trademark Owner History

Sarepta Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform; Pharmaceutical preparations that modulate RNA expression; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases

16 Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders

44 Medical information services, namely, providing information relating to of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders; Providing a website and information in the field of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders; Provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options

42 Medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs

Trademark Events

Jan 17, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 16, 2023

Abandonment - No Use Statement Filed

Jun 15, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 13, 2022

Sou Extension 4 Granted

Jun 13, 2022

Sou Extension 4 Filed

Jun 13, 2022

Sou Teas Extension Received

Dec 4, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 2, 2021

Sou Extension 3 Granted

Dec 2, 2021

Sou Extension 3 Filed

Dec 2, 2021

Sou Teas Extension Received

May 20, 2021

Notice Of Approval Of Extension Request E-Mailed

May 18, 2021

Sou Extension 2 Granted

May 18, 2021

Sou Extension 2 Filed

May 18, 2021

Sou Teas Extension Received

Dec 10, 2020

Notice Of Approval Of Extension Request E-Mailed

Dec 8, 2020

Sou Extension 1 Granted

Dec 8, 2020

Sou Extension 1 Filed

Dec 8, 2020

Sou Teas Extension Received

Jun 16, 2020

Noa E-Mailed - Sou Required From Applicant

Apr 21, 2020

Official Gazette Publication Confirmation E-Mailed

Apr 21, 2020

Published For Opposition

Apr 1, 2020

Notification Of Notice Of Publication E-Mailed

Mar 13, 2020

Approved For Pub - Principal Register

Mar 13, 2020

Assigned To Examiner

Mar 6, 2020

New Application Office Supplied Data Entered

Mar 5, 2020

New Application Entered